Edit |   |
---|---|
Antigenic Specificity | CD13, Human |
Clone | REA263 |
Host Species | Recombinant Human |
Reactive Species | human |
Isotype | IgG1 |
Format | Vio Bright B515 conjugate |
Size | 30 tests in 60 µL |
Concentration | 1:50 |
Applications | Flow cytometry |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | CD13 Antibody, anti-human, Vio® Bright B515, REAfinity™. Clone REA263 recognizes the CD13 antigen, a 150-170 kDa type II transmembrane glycoprotein, which is also known as aminopeptidase N or gp150. CD13 is expressed on granulocytes, myeloid progenitors, endothelial cells, epithelial cells, and subset of granular lymphoid cells. It is also broadly expressed in other tissues such as kidney proximal tubules, intestine, and placenta. CD13 is an enzyme that is used as a biomarker to detect damage to the kidneys, and that may be used to help diagnose certain kidney disorders. It also serves as a receptor for one strain of human coronavirus that is an important cause of upper respiratory tract infections. Defects in CD13 appear to be a cause of various types of leukemia or lymphoma. | Additional information: Clone REA263 displays negligible binding to Fc receptors. | |
Immunogen | n/a |
Other Names | ANPEP, APN, gp150, LAP1, p150, PEPN |
Gene, Accession # | Gene ID: 290 |
Catalog # | 130-129-522 |
Price | $201 |
Order / More Info | CD13, Human Antibody from MILTENYI BIOTEC B.V. & Co. KG |
Product Specific References | Look, A. T. et al. (1989) Human myeloid plasma membrane glycoprotein CD13 (gp150) is identical to aminopeptidase N. J. Clin. Invest. 83 (4): 1299-1307. | Favaloro, E. J. et al. (1993) CD13 (GP150; aminopeptidase-N): predominant functional activity in blood is localized to plasma and is not cell-surface associated. Exp. Hematol. 21 (13): 1695-1701. | Yeager, C. L. et al. (1992) Human aminopeptidase N is a receptor for human coronavirus 229E. Nature 357 (6377): 420-422. |